• Company
• The Brain disease prescription market disappears
• by Chon, Seung-Hyun Jan 19, 2023 05:59am

• Company
• Generic drugs occupy 41% of antidiabetics market in 9 mths
• by Kim, Jin-Gu Jan 19, 2023 05:58am

• Policy
• Grace period for foreign API mfg site registrations ends
• by Lee, Hye-Kyung Jan 19, 2023 05:58am

• Product
• Viatris Korea, "Viagra's supply expected on Jan 23"
• by Kim JiEun Jan 19, 2023 05:58am

• Company
• Paclitaxel copyright transfer
• by Kim, Jin-Gu Jan 19, 2023 05:58am

• Policy
• Generic for Dukarb to be released next month
• by Lee, Tak-Sun Jan 18, 2023 06:04am

• Opinion
• [Reporter’s View] Our expectations for ADC technology
• by Jan 18, 2023 06:04am

• Company
• The Canadian gov. has put the drug price system on hold
• by Kim, Jin-Gu Jan 18, 2023 06:04am

• Policy
• MOHW-NECA issues notice on colorimetric assay
• by Kim, Jung-Ju Jan 18, 2023 06:04am

• Company
• Biktarvy, applies to the expansion of pediatric indications
• by Eo, Yun-Ho Jan 18, 2023 06:04am